Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: The mid-year check-in

Over the past few weeks, volatility has seemingly returned to the markets, and the most-viewed stocks have been in constant upheaval because of it. For investors focused on the markets and small-c...
Jonathon Brown | June 2, 2022 |

Swiss Franc Is Going from Strength to Strength, Seemingly Unstoppable

The Swiss franc certainly appears to be in high demand lately but can it keep strengthening? With today’s candle being a bearish one, it seems one question too many. But let’s take a thorough look at the situation for what it is. USD/CH...
Nadia Simmons | December 18, 2019 |

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...
According to published reports | May 6, 2021 |

There Is Still Time To Get Silver

Silver appears to be very close to an even bigger move higher. Most of the hard work of the double-bottom since 2015 is done. The coming leg higher is the one that will likely take prices to all-time highs. Below, is a long-term Silver chart: Note that price has b...
Hubert Moolman | January 16, 2020 |

Buzz on the Bullboards: PyroGenesis, Antibe Top All Sectors

The reign of COVID-19 related gains is over on the Stockhouse Bullboards. Instead, the new king comes from the unlikeliest of sectors: Industrials. Of course, it’s not surprising to have a profitable and quickly rising small-cap company in the industrials s...
Omri Wallach | June 17, 2020 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

A Real Blockchain Developer goes live, eXeBlock Technology (CSE:XBLK)

Last night I attended the Grit Capital's Banking on Blockchain event in Vancouver, along with seemingly every person I've ever met in this city's financial scene. The place was packed - standing room only in a ballroom that usually seats 300+. HIVE Blockchain (HIVE.V) ...
Chris Parry | November 17, 2017 |

Taking Advantage of the AUD Bulls’ Waning Strength

Seemingly unstoppable, the Australian dollar has been on a winning streak recently. Yet the bulls wavered in their efforts not so long ago. Is it a sign that the tide is beginning to turn? Or, is it turning already? We wrote on Monday that the recent AUD/USD upswing: ...
Nadia Simmons | January 3, 2020 |

ConocoPhillips (COP): Playing the crack spread

There’s a lot of talk about diversification and asset allocation on this website, and rightly so. While diversification can limit large short-term gains, it also protects against large short-term losses. Since the markets tend to be unpredictable, it&CloseC...
Justin Dove | October 28, 2012 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |
1 2 3 4 5 6 7